We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+1.4%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.98%
AUM
$148B
AUM Growth
+$8.19B
Cap. Flow
+$6.46B
Cap. Flow %
4.35%
Top 10 Hldgs %
18.71%
Holding
2,935
New
79
Increased
1,853
Reduced
707
Closed
50

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$495M
2
MSFT icon
Microsoft
MSFT
+$480M
3
GPN icon
Global Payments
GPN
+$400M
4
MA icon
Mastercard
MA
+$274M
5
CMCSA icon
Comcast
CMCSA
+$254M

Sector Composition

Rank Sector Weight
1 Technology 18.77%
2 Financials 14.07%
3 Healthcare 13.13%
4 Consumer Discretionary 12.1%
5 Communication Services 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKBA icon
2401
Akebia Therapeutics
AKBA
$251M
$315K ﹤0.01%
80,309
+5,478
+7% +$23.5K
QQQ icon
2402
Invesco QQQ Trust
QQQ
$484B
$315K ﹤0.01%
1,666
-20
-1% -$3.79K
FLXN
2403
DELISTED
Flexion Therapeutics, Inc.
FLXN
$314K ﹤0.01%
22,928
+12,770
+126% +$152K
LL
2404
DELISTED
LL Flooring Holdings, Inc.
LL
$313K ﹤0.01%
31,697
+1,835
+6% +$18K
RGP icon
2405
Resources Connection
RGP
$145M
$313K ﹤0.01%
18,398
EGIO
2406
DELISTED
Edgio, Inc. Common Stock
EGIO
$313K ﹤0.01%
2,579
+656
+34% +$69.2K
CHUY
2407
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$312K ﹤0.01%
+12,599
New +$305K
VIG icon
2408
Vanguard Dividend Appreciation ETF
VIG
$114B
$310K ﹤0.01%
2,594
-157
-6% -$18.5K
GOGO icon
2409
Gogo Inc
GOGO
$491M
$309K ﹤0.01%
51,301
-9,668
-16% -$45.6K
TS icon
2410
Tenaris
TS
$26.8B
$309K ﹤0.01%
14,589
AMRX icon
2411
Amneal Pharmaceuticals
AMRX
$5.8B
$309K ﹤0.01%
106,476
+15,769
+17% +$55K
BTE icon
2412
Baytex Energy
BTE
$2.92B
$304K ﹤0.01%
205,484
-459,238
-69% -$658K
SWBI icon
2413
Smith & Wesson
SWBI
$637M
$304K ﹤0.01%
67,609
+14,160
+26% +$85.4K
PRTY
2414
DELISTED
Party City Holdco Inc.
PRTY
$303K ﹤0.01%
53,118
+4,313
+9% +$24.6K
ITCI
2415
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$303K ﹤0.01%
40,581
+9,117
+29% +$87.4K
PGNX
2416
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$303K ﹤0.01%
59,875
+12,864
+27% +$64.2K
BYND icon
2417
Beyond Meat
BYND
$277M
$302K ﹤0.01%
+2,031
New +$334K
TLRY icon
2418
Tilray
TLRY
$624M
$302K ﹤0.01%
1,220
-208
-15% -$75.8K
VONG icon
2419
Vanguard Russell 1000 Growth ETF
VONG
$45.1B
$301K ﹤0.01%
7,344
+4,256
+138% +$175K
AAIC
2420
DELISTED
Arlington Asset Investment Corp.
AAIC
$300K ﹤0.01%
54,696
+27,875
+104% +$164K
CYH icon
2421
Community Health Systems
CYH
$423M
$299K ﹤0.01%
83,136
-79,527
-49% -$207K
GTT
2422
DELISTED
GTT Communications, Inc.
GTT
$299K ﹤0.01%
31,693
+21,293
+205% +$239K
BGG
2423
DELISTED
Briggs & Stratton Corp.
BGG
$297K ﹤0.01%
49,039
+8,936
+22% +$66K
ATSG
2424
DELISTED
Air Transport Services Group
ATSG
$297K ﹤0.01%
14,130
-3,579
-20% -$78.1K
RDS.A
2425
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$296K ﹤0.01%
5,035
+103
+2% +$6.11K

Similar funds

UBS AM's Q3 2019 Portfolio in Review

As of Q3 2019, UBS AM held 2,935 positions worth $148B, up 5.8% from $140B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

UBS AM deployed $6.46B of net new capital in Q3 2019, opening 79 new positions and adding to 1,853 existing holdings. Its largest new stake was 10x Genomics: 184,683 shares worth $9.31M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $167M trimmed.

  • UBS AM's largest Q3 2019 buy was 10x Genomics: 184,683 shares worth $9.31M.
  • UBS AM added most to Alibaba in Q3 2019, an estimated $495M increase.
  • UBS AM's biggest Q3 2019 reduction was Apple, cutting an estimated $167M.
  • UBS AM fully exited Total System Services, Inc. in Q3 2019, selling an estimated $225M.
  • UBS AM's ten largest holdings make up 19% of its $148B portfolio in Q3 2019.
  • UBS AM opened 79 new positions and closed 50 in Q3 2019.
  • UBS AM's portfolio value rose 5.8% quarter-over-quarter to $148B.

Based on UBS AM's 13F filing for Q3 2019, filed 14 Nov 2019.